{"id":"https://openalex.org/W2623479216","doi":"https://doi.org/10.1177/1179554917702870","title":"BCR-ABL V280G Mutation, Potential Role in Imatinib Resistance: First Case Report","display_name":"BCR-ABL V280G Mutation, Potential Role in Imatinib Resistance: First Case Report","publication_year":2017,"publication_date":"2017-01-01","ids":{"openalex":"https://openalex.org/W2623479216","doi":"https://doi.org/10.1177/1179554917702870","mag":"2623479216","pmid":"https://pubmed.ncbi.nlm.nih.gov/28469513","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5395261"},"language":"en","primary_location":{"id":"doi:10.1177/1179554917702870","doi":"https://doi.org/10.1177/1179554917702870","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1179554917702870","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/1179554917702870","source":{"id":"https://openalex.org/S1031084011","display_name":"Clinical Medicine Insights Oncology","issn_l":"1179-5549","issn":["1179-5549"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Medicine Insights: Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.sagepub.com/doi/pdf/10.1177/1179554917702870","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020349170","display_name":"Ana Paula Azevedo","orcid":"https://orcid.org/0000-0002-7457-3245","observed_orcids":["https://orcid.org/0000-0002-7457-3245"]},"institutions":[{"id":"https://openalex.org/I4210106487","display_name":"Hospital de Egas Moniz","ror":"https://ror.org/012habm93","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210106487"]},{"id":"https://openalex.org/I4210124394","display_name":"Centro Hospitalar de Lisboa Ocidental","ror":"https://ror.org/036ypft38","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210124394"]},{"id":"https://openalex.org/I4210136214","display_name":"Hospital of St. Francis Xavier","ror":"https://ror.org/03qxkp346","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210136214"]},{"id":"https://openalex.org/I83558840","display_name":"Universidade Nova de Lisboa","ror":"https://ror.org/02xankh89","country_code":"PT","type":"education","lineage":["https://openalex.org/I83558840"]}],"countries":["PT"],"is_corresponding":true,"raw_author_name":"Ana P Azevedo","raw_affiliation_strings":["Centre for Toxicogenomics and Human Health, Genetics, Oncology and Human Toxicology, NOVA Medical School/Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Lisboa, Portugal","Department of Clinical Pathology, Hospital S\u00e3o Francisco Xavier, Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Toxicogenomics and Human Health, Genetics, Oncology and Human Toxicology, NOVA Medical School/Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Lisboa, Portugal","institution_ids":["https://openalex.org/I83558840"]},{"raw_affiliation_string":"Department of Clinical Pathology, Hospital S\u00e3o Francisco Xavier, Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal","institution_ids":["https://openalex.org/I4210106487","https://openalex.org/I4210124394","https://openalex.org/I4210136214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108191475","display_name":"Alice Reichert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106487","display_name":"Hospital de Egas Moniz","ror":"https://ror.org/012habm93","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210106487"]},{"id":"https://openalex.org/I4210122709","display_name":"Hospital de Santa Cruz","ror":"https://ror.org/02r581p42","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210122709"]},{"id":"https://openalex.org/I4210124394","display_name":"Centro Hospitalar de Lisboa Ocidental","ror":"https://ror.org/036ypft38","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210124394"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Alice Reichert","raw_affiliation_strings":["Department of Hematology, Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal","institution_ids":["https://openalex.org/I4210106487","https://openalex.org/I4210122709","https://openalex.org/I4210124394"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055666816","display_name":"Celina Afonso","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106487","display_name":"Hospital de Egas Moniz","ror":"https://ror.org/012habm93","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210106487"]},{"id":"https://openalex.org/I4210122709","display_name":"Hospital de Santa Cruz","ror":"https://ror.org/02r581p42","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210122709"]},{"id":"https://openalex.org/I4210124394","display_name":"Centro Hospitalar de Lisboa Ocidental","ror":"https://ror.org/036ypft38","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210124394"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Celina Afonso","raw_affiliation_strings":["Department of Hematology, Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal","institution_ids":["https://openalex.org/I4210106487","https://openalex.org/I4210122709","https://openalex.org/I4210124394"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063231419","display_name":"Maria D Alberca","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106487","display_name":"Hospital de Egas Moniz","ror":"https://ror.org/012habm93","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210106487"]},{"id":"https://openalex.org/I4210122709","display_name":"Hospital de Santa Cruz","ror":"https://ror.org/02r581p42","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210122709"]},{"id":"https://openalex.org/I4210124394","display_name":"Centro Hospitalar de Lisboa Ocidental","ror":"https://ror.org/036ypft38","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210124394"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Maria D Alberca","raw_affiliation_strings":["Department of Oncology, Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal","institution_ids":["https://openalex.org/I4210106487","https://openalex.org/I4210122709","https://openalex.org/I4210124394"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112695100","display_name":"Purifica\u00e7\u00e3o Tavares","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089763","display_name":"Centro de Gen\u00e9tica Cl\u00ednica","ror":"https://ror.org/007sw5k32","country_code":"PT","type":"facility","lineage":["https://openalex.org/I4210089763"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Purifica\u00e7\u00e3o Tavares","raw_affiliation_strings":["CGC-Genetics/Centro de Gen\u00e9tica Cl\u00ednica, Lisboa, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CGC-Genetics/Centro de Gen\u00e9tica Cl\u00ednica, Lisboa, Portugal","institution_ids":["https://openalex.org/I4210089763"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102578235","display_name":"Fernando Lima","orcid":"https://orcid.org/0000-0001-6103-5889","observed_orcids":["https://orcid.org/0000-0001-6103-5889"]},"institutions":[{"id":"https://openalex.org/I4210106487","display_name":"Hospital de Egas Moniz","ror":"https://ror.org/012habm93","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210106487"]},{"id":"https://openalex.org/I4210122709","display_name":"Hospital de Santa Cruz","ror":"https://ror.org/02r581p42","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210122709"]},{"id":"https://openalex.org/I4210124394","display_name":"Centro Hospitalar de Lisboa Ocidental","ror":"https://ror.org/036ypft38","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210124394"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Fernando Lima","raw_affiliation_strings":["Department of Hematology, Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal","institution_ids":["https://openalex.org/I4210106487","https://openalex.org/I4210122709","https://openalex.org/I4210124394"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5020349170"],"corresponding_institution_ids":["https://openalex.org/I4210106487","https://openalex.org/I4210124394","https://openalex.org/I4210136214","https://openalex.org/I83558840"],"apc_list":{"value":2650,"currency":"USD","value_usd":2650},"apc_paid":{"value":2650,"currency":"USD","value_usd":2650},"fwci":0.8257,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.72725259,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"11","issue":"11","first_page":"1179554917702870","last_page":"1179554917702870"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/imatinib-resistance","display_name":"imatinib resistance","score":0.9900000095367432},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9789999723434448},{"id":"https://openalex.org/keywords/philadelphia-chromosome-positive-cml","display_name":"Philadelphia chromosome-positive CML","score":0.8320000171661377},{"id":"https://openalex.org/keywords/bcr-abl-tyrosine-kinase-inhibitors","display_name":"BCR-ABL tyrosine kinase inhibitors","score":0.8930000066757202},{"id":"https://openalex.org/keywords/kinase-domain-mutations","display_name":"kinase domain mutations","score":0.7229999899864197},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5889999866485596}],"concepts":[{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.9094497561454773},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.675815999507904},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5553777813911438},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.5439313650131226},{"id":"https://openalex.org/C125418893","wikidata":"https://www.wikidata.org/wiki/Q587961","display_name":"ABL","level":4,"score":0.5418790578842163},{"id":"https://openalex.org/C2778904597","wikidata":"https://www.wikidata.org/wiki/Q1129111","display_name":"Philadelphia chromosome","level":4,"score":0.5288456678390503},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4901004731655121},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.48226410150527954},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.4695345163345337},{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.4556905925273895},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.4299622178077698},{"id":"https://openalex.org/C43907098","wikidata":"https://www.wikidata.org/wiki/Q903924","display_name":"breakpoint cluster region","level":3,"score":0.4190021753311157},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3304252028465271},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.32259517908096313},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30637097358703613},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.24085098505020142},{"id":"https://openalex.org/C138626823","wikidata":"https://www.wikidata.org/wiki/Q916504","display_name":"Chromosomal translocation","level":3,"score":0.1131308376789093},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.10325035452842712},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.10313823819160461},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.07363733649253845}],"mesh":[],"locations_count":7,"locations":[{"id":"doi:10.1177/1179554917702870","doi":"https://doi.org/10.1177/1179554917702870","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1179554917702870","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/1179554917702870","source":{"id":"https://openalex.org/S1031084011","display_name":"Clinical Medicine Insights Oncology","issn_l":"1179-5549","issn":["1179-5549"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Medicine Insights: Oncology","raw_type":"journal-article"},{"id":"pmid:28469513","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28469513","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Medicine Insights. Oncology","raw_type":"Case Reports"},{"id":"pmh:oai:pubmedcentral.nih.gov:5395261","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5395261/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Med Insights Oncol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:4137f79adbbc413c94bc9bd74cce7ca2","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/4137f79adbbc413c94bc9bd74cce7ca2","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical Medicine Insights: Oncology, Vol 11 (2017)","raw_type":"article"},{"id":"pmh:oai:libertasacademica.com/6272","doi":null,"is_oa":false,"landing_page_url":"http://insights.sagepub.com/redirect_file.php?fileId=8488&filename=10.1177_1179554917702870.pdf&fileType=pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://insights.sagepub.com/v280g-mutation-potential-role-in-imatinib-resistance-first-case-report-article-a6272","raw_type":null},{"id":"pmh:oai:run.unl.pt:10362/27823","doi":null,"is_oa":false,"landing_page_url":"https://www.scopus.com/inward/record.uri?eid=2-s2.0-85034627995&doi=10.1177%2f1179554917702870&partnerID=40&md5=2f9e733c9917a0a3235f85279d0de323","pdf_url":null,"source":{"id":"https://openalex.org/S4306401014","display_name":"New University of Lisbon's Repository (New University of Lisbon)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"journal article"},{"id":"mag:3119938058","doi":null,"is_oa":false,"landing_page_url":"http://insights.sagepub.com/redirect_file.php?fileId=8488&filename=10.1177_1179554917702870.pdf&fileType=pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"doi:10.1177/1179554917702870","doi":"https://doi.org/10.1177/1179554917702870","is_oa":true,"landing_page_url":"https://doi.org/10.1177/1179554917702870","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/1179554917702870","source":{"id":"https://openalex.org/S1031084011","display_name":"Clinical Medicine Insights Oncology","issn_l":"1179-5549","issn":["1179-5549"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Medicine Insights: Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W2623479216.pdf"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W1589238845","https://openalex.org/W1703585081","https://openalex.org/W1799579309","https://openalex.org/W1917533840","https://openalex.org/W1944560152","https://openalex.org/W1968747503","https://openalex.org/W1979107490","https://openalex.org/W2016809033","https://openalex.org/W2028669471","https://openalex.org/W2031161823","https://openalex.org/W2044937696","https://openalex.org/W2048662229","https://openalex.org/W2049253745","https://openalex.org/W2064106548","https://openalex.org/W2070375208","https://openalex.org/W2088110060","https://openalex.org/W2107268345","https://openalex.org/W2117806883","https://openalex.org/W2122443624","https://openalex.org/W2149322936","https://openalex.org/W2158490265","https://openalex.org/W2165537263","https://openalex.org/W2194645485","https://openalex.org/W2253701464","https://openalex.org/W2260921597","https://openalex.org/W2299907835","https://openalex.org/W2300661748","https://openalex.org/W2397234997","https://openalex.org/W2416721762","https://openalex.org/W2563100240"],"related_works":["https://openalex.org/W2576552777","https://openalex.org/W4393992341","https://openalex.org/W4390168884","https://openalex.org/W2095269243","https://openalex.org/W2531529535","https://openalex.org/W2980207641","https://openalex.org/W2915812778","https://openalex.org/W2949691695","https://openalex.org/W2588442229","https://openalex.org/W2591882348"],"abstract_inverted_index":{"Introduction:":[0],"The":[1],"identification":[2],"of":[3,19,45,61,109,133],"BCR-ABL":[4,20,81,94,124],"expression":[5],"as":[6],"the":[7,17,42,56,59,88],"defining":[8],"leukemogenic":[9],"event":[10],"in":[11,24,34,41],"chronic":[12],"myeloid":[13],"leukemia":[14],"(CML)":[15],"and":[16,37,53,84,140],"introduction":[18],"tyrosine":[21],"kinase":[22,95],"inhibitors":[23],"2001":[25],"have":[26],"revolutionized":[27],"disease":[28],"management,":[29],"leading":[30],"to":[31,70,103,107,117],"a":[32,62,79,92],"reduction":[33],"mortality":[35],"rates":[36],"accordingly":[38],"an":[39],"increase":[40],"estimated":[43],"prevalence":[44],"CML.":[46],"Case":[47],"report:":[48],"Based":[49],"on":[50],"medical":[51],"records":[52],"clinical":[54],"follow-up,":[55],"authors":[57],"present":[58],"case":[60],"Philadelphia":[63],"chromosome\u2013positive":[64],"CML":[65],"patient":[66],"who":[67],"developed":[68],"resistance":[69,102,118],"imatinib.":[71,104],"Quantitative":[72],"reverse":[73],"transcription-polymerase":[74],"chain":[75],"reaction":[76],"testing":[77],"revealed":[78],"V280G":[80],"mutation.":[82],"Discussion":[83],"conclusions:":[85],"This":[86],"is":[87],"first":[89],"report":[90],"describing":[91],"new":[93],"domain":[96],"mutation\u2014V280G\u2014that":[97],"might":[98],"be":[99],"associated":[100],"with":[101,112,136],"Approximately":[105],"15%":[106],"30%":[108],"patients":[110],"treated":[111],"imatinib":[113],"discontinue":[114],"treatment":[115],"due":[116],"or":[119],"intolerance.":[120],"More":[121],"than":[122],"90":[123],"mutations":[125],"were":[126],"detected":[127],"so":[128],"far,":[129],"conferring":[130],"variable":[131],"degrees":[132],"drug":[134],"resistance,":[135],"consequent":[137],"clinical,":[138],"therapeutic,":[139],"prognostic":[141],"impact.":[142]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2017-06-15T00:00:00"}